Peer Review History

Original SubmissionDecember 2, 2024
Decision Letter - Justyna Żywiołek, Editor

PONE-D-24-54151Investigating the Key Trends in Applying Artificial Intelligence to Health Technologies: A Scoping ReviewPLOS ONE

Dear Dr. Tawil,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 27 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Justyna Żywiołek

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors,

The article is very appropriate considering the importance of the field of artificial intelligence

The article abstract does not mention the objectives, method, and data collection method well

The results were reviewed in the abstract.

In the method:

The method should be clearly specified and its parts should be specified

The prism table should be specified in it

The findings in this study and its classification are appropriate

State the limitations if any

In the method, the number of reviews and independent person is three. What is the role of the third person?

Reviewer #2: The manuscript describes a technically sound piece of scientific research with data that supports the conclusion. Methodology is quite detailed and covers everything. I recommend that the article should be copy-edited by a professional to address minor grammatical, punctuation and typo mistakes (highlighted later in each section).

Use Clear, Concise Language: Avoid overly complex sentences and jargon. Opt for clear, direct phrasing. (Added few examples in the review document)

Summerize the limitations and future recommendations with clear directions.

Results

Condense Descriptive Language: Minimize excessive narrative and refer to tables for detailed figures.

- Example: Instead of “A% of articles in B field, X% in Y field and ....." consider summarizing with “X% of articles have been found in Oncology (see Table 2 for details).”

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-24-54151_reviewer.pdf
Attachment
Submitted filename: Reviewers comments -AI in Healthcare-.pdf
Revision 1

Dear Editor,

On behalf of the authors, I would like to thank you for the reviewers’ comments. Please find below detailed responses to each of the addressed comments:

Comments Responses

Journal Requirements

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming - Requirements reviewed and amended as per the journal requirement

We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

- All relevant data are within the manuscript and its Supporting Information files (a supporting file was included to give an idea about the studies selected)

Reviewers’ comments

Reviewer 1

Overall, I recommend that the article should be copy-edited by a professional to address minor grammatical, punctuation and typo mistakes - Comment addressed and manuscript was reviewed and copy-edited as required

Abstract: - The aims and objectives should be defined more clearly. For instance, rather than stating, “This study presents a scoping review of …,” the authors should elaborate on the necessity of this study - Comment addressed and modification done as requested

Introduction: The introduction is well-structured and provides a clear research question and objectives. However, some refinements are suggested: Line 63: In the sentence, “Certain devices, utilizing an interdisciplinary approach …,” the authors should provide examples or names of these devices and include appropriate citations - Comments addressed and modification done as requested

Line 73: The sentence, “AI has become an indispensable tool in various medical applications, revolutionizing traditional practices,” should be removed as it reiterates content already covered in previous sentences. - Sentence removed as per suggestion

Line 74: The sentence, “Several studies exemplify the integration of artificial intelligence into medicine,” appears overstated and adds little value. Consider removing it. - Sentence removed as per suggestion

Line 75: Sentence "artificially intelligent computer systems inpatient diagnosis" likely contains a typo. It should read "artificially intelligent computer systems in patient diagnosis." - Sentence was removed as per suggestion since it doesn’t fit anymore

Line 87: The sentence, “The Middle East and North Africa region acknowledged the vital importance of adapting…..” is quite lengthy. For improved readability, it can be split into two sentences. For example: “The Middle East and North Africa Region acknowledged the vital importance of adapting to new technologies. They recognized the key role of these technologies in transforming the region and advancing to the forefront of the digital economy and healthcare.” - Sentence corrected as per your suggestion

Line 97: Discussion of Lebanon’s setbacks during COVID-19 can be made more concise by removing jargon - Jargon removed and sentence was reformulated

Line 110: There is a minor grammatical error,

it should be “What AI methodologies have been applied for healthcare systems in Lebanon?" - Sentence corrected as per your suggestion

Materials and Methods:

Line 117-118: Ensure a consistent format for the year range filter, such as "2020 to 2024" or "January 2020 to April 2024." - Sentence corrected as per your suggestion

In the section “Publication Characteristics,” it is mentioned that studies were selected from 2020 to 2023. For clarity, use a clear and consistent range for reviewers and readers. - The mistake was corrected as per your suggestion

Line 118: Replace “following keywords” with “these keywords” for technical accuracy. - Sentence corrected as per your suggestion

Lines 127-130: The sentence discussing the choice of scoping review over systematic review could be rephrased to present a more positive perspective. For instance: "A scoping review was chosen over a systematic review because it allows for a broader exploration of the literature and identification of key concepts and research gaps, which is more suitable for this study given the heterogeneity of the included studies." - Paragraph amended as per your suggestion. Thank you for the rephrase.

Line 149: Replace the typo "v7" with "(7)." - Typo error was corrected as per your suggestion

Line 167: The sentence, “Main findings from the studies were reviewed using descriptive and analytical methods based on different variables outcomes,” should specify the variables for clarity. - Variables were specified and more detailed

Results:

Line 187: The sentence, “The most common reasons for excluding some journal articles after full-text review …,” could be made more specific.

For example: "The most common reasons for excluding articles after full-text review included lack of relevance to the research question and AI not being the primary focus or methodology." - Paragraph amended and corrected as per your suggestion. Thank you for the rephrase.

Line 231: There is a discrepancy between the number of articles per quartile mentioned in the text and Table 2. This should be reconciled - The quartiles were reviewed and the mistake was corrected

Line 244: Replace “didn't” with “did not” to align with academic writing standards. - Correction made as per your suggestion

Lines 253-255: Clarify how many studies fall under each domain to ensure better understanding for the general audience - The number of studies that fall under each category is specified in the sentence following this statement. Percentages were added to make the figure clearer for the audience.

Discussion:

Lines 376-382: Concise this paragraph to 2-3 sentences - Paragraph amended and rephrased according to you recommendation

Lines 388-391: This paragraph could benefit from restructuring for smoother flow.

For example: "Our findings indicate that AI applications in healthcare are predominantly focused on diagnosing and predicting diseases such as cancer, cardiovascular diseases, infectious diseases, and neurological disorders. This focus enhances patient care by allowing healthcare professionals to spend more time with patients, adopt a holistic care approach, and improve patient satisfaction - Paragraph was restricted according to your suggestion. Thank you for the rephrase

Lines 422-423: Strengthen the sentence by briefly summarizing the specific challenges reported in the cited studies. - Sentence amended as per your suggestion

Conclusion:

Line 475: Specify that the study focuses on Lebanon rather than referring to an unspecified Middle Eastern country. - Corrected as per your suggestion

Reviewer 2

The purpose of the study should be specified

The method should be modified, for example, the names of the databases should be included:

Databases: Scopus, PubMed, CINAHL, PsycINFO

Based on what time efficiency the search was performed

Review method

The number of articles should be included in the findings and the characteristics of the number of articles

The findings should be better explained

- The purpose was added. Methods were modified and databases were included. Time efficacy was also added. The number of articles were included and the findings were better explained according to your suggestion

In the study, it refers to the O'Malley method. Based on what method or standard did you proceed and in how many stages?

- Each of the research question specified at the end of the “Introduction” section was answered in the results and discussion sections. As for the methods, searching for relevant studies, selecting studies, and charting the data were detailed in the methods section whereas collating data, summarizing it, and reporting the results are detailed and tabulated in the results section.

Review steps should be written down precisely

- Steps were revised and reformulated more precisely as per your suggestion

It would be better to include it in the table.

- All the 68 studies were added to the table. Specific number of studies obtained from different databases was added to Table 1 as per your suggestion

In the method, the number of reviews and independent person is three. What is the role of the third person?

- To ensure methodological rigidity, a third auditor was consulted in case of any discrepancies, and a consensus on article eligibility was reached through rechecking the information. A more detailed explication was added to the text manuscript

Insert Prism table - Flow diagram is already presented in Figure 1.

Title should be included in tables.

- Titles were added and the table was amended as per your suggestion

Limitations - The limitations section was revised and amended as per your suggestion

Attachments
Attachment
Submitted filename: Rebuttal letter 1.docx
Decision Letter - Justyna Żywiołek, Editor

Investigating the Key Trends in Applying Artificial Intelligence to Health Technologies: A Scoping Review

PONE-D-24-54151R1

Dear Dr. Tawil,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Justyna Żywiołek

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: All points required for the structural composition of a scoping review were met. The composition of the text is acceptable for publication and the theme has profound relevance to the research area.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #3: No

**********

Formally Accepted
Acceptance Letter - Justyna Żywiołek, Editor

PONE-D-24-54151R1

PLOS ONE

Dear Dr. Samah,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Justyna Żywiołek

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .